Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonafarnib plus anastrozole in advanced breast cancer
NCT00081510Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Dec 2003
- Primary completion
- May 2009
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of lonafarnib in breast cancer, sponsored by Merck & Co.. Started Dec 2003; status: completed.
02
Drugs
lonafarnib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00081510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00081510.